In anticipation of the official implementation of the United States Pharmacopoeia Chapter <232> Elemental Impurities—Limits and <233> Elemental Impurities—Procedures in August of 2015, pharmaceutical manufacturers are turning to their supply chain for higher purity raw materials that are already tested to more rigid standards.<br />
<br />
USP<232> outlines a number of proposed changes, including increasing the Permitted Daily Exposure (PDE) limits from 10 to 16 analytes with the ...This story is related to the following:Spectroscopes | Measuring Instruments